Swallowable expandable fibrous capsules for nonendoscopic sampling of esophageal cells

Esophageal adenocarcinoma is a highly lethal malignancy with a 5-year survival rate of only 18.8%, largely due to late-stage diagnosis in the absence of effective population-wide screening. Survival improves to 42.9% when detected at a localized stage (I/II). More than 90% of esophageal adenocarcinoma cases are diagnosed without prior identification of Barrett's esophagus, its only known precursor. We present a swallowable, string-tethered capsule that expands in the stomach to enable atraumatic retrieval of esophageal epithelial cells without sedation or endoscopic guidance, completing the procedure in under 3 minutes. Capsules are fabricated via gas-foamed expansion of nanofiber mats or hybrid aerogel formation, enabling rapid in situ reexpansion upon gastric fluid exposure and safe retrieval. In swine studies, capsules dissolved within 2 minutes, reexpanded within seconds, required minimal retrieval force, and consistently captured intact epithelial layers without injury. This platform could enable low-cost, high-throughput esophageal sampling in primary care and resource-limited settings.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2025-11-12
DOI
https://doi.org/10.1126/sciadv.aeb3892
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Swallowable expandable fibrous capsules for nonendoscopic sampling of esophageal cells

Farzad Hayati, Navatha Shree Sharma, S. M. Shatil Shahriar, Jingwei Xie et al.
Science Advances
Esophageal Cancer Research and Treatment
article

Swallowable expandable fibrous capsules for nonendoscopic sampling of esophageal cells

Farzad Hayati, Navatha Shree Sharma, S. M. Shatil Shahriar, Jingwei Xie, Imran Rather, Syed Muntazir Andrabi, Zishuo Yan, Huy Quang Tran
article en

Abstract

Esophageal adenocarcinoma is a highly lethal malignancy with a 5-year survival rate of only 18.8%, largely due to late-stage diagnosis in the absence of effective population-wide screening. Survival improves to 42.9% when detected at a localized stage (I/II). More than 90% of esophageal adenocarcinoma cases are diagnosed without prior identification of Barrett's esophagus, its only known precursor. We present a swallowable, string-tethered capsule that expands in the stomach to enable atraumatic retrieval of esophageal epithelial cells without sedation or endoscopic guidance, completing the procedure in under 3 minutes. Capsules are fabricated via gas-foamed expansion of nanofiber mats or hybrid aerogel formation, enabling rapid in situ reexpansion upon gastric fluid exposure and safe retrieval. In swine studies, capsules dissolved within 2 minutes, reexpanded within seconds, required minimal retrieval force, and consistently captured intact epithelial layers without injury. This platform could enable low-cost, high-throughput esophageal sampling in primary care and resource-limited settings.

Science AdvancesVol. 11(46)
University of Nebraska–Lincoln (US), Nebraska Medical Center (US), University of Nebraska Medical Center (US)
Openalex Percentile: Top 47%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Swallowable expandable fibrous capsules for nonendoscopic sampling of esophageal cells — Farzad Hayati, Navatha Shree Sharma, et al. · Science Advances (2025) | TGRS Research Map | TGRS